Balaji Amines working capital

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
119.43×119.43×131.08×119.16×76.93×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
79.55×79.55×77.68×77.51×74.84×
35.34×35.34×34.34×28.30×34.96×
163.64×163.64×174.42×168.37×116.81×
2.83×2.64×1.72×1.94×2.67×
0.57×0.57×0.64×0.80×1.23×
1.09×1.09×1.61×0.95×0.94×
0.69×0.69×1.10×0.68×0.63×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BALAMINES₹1,848.80

Balaji Amines Ltd.

· Chemicals
₹ CrorePeersALKYLAMINEDEEPAKNTRTECILCHEMAETHERACIELLENGHCLGNFCMcap ₹5,990 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)76.93119.16131.08119.43119.43
Receivable Days (DSO)74.8477.5177.6879.5579.55
Payable Days (DPO)34.9628.3034.3435.3435.34
Cash Conversion Cycle (days)116.81168.37174.42163.64163.64
Working Capital Turnover2.671.941.722.642.83
Asset Turnover1.230.800.640.570.57
Cash Conversion (CFO/Net Income)0.940.951.611.091.09
CFO/EBITDA0.630.681.100.690.69
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.